You searched for
We found 9 articles
Assessment of Chronic Guillain-Barre Syndrome Improvement with Use of 4-aminopyridine
In developed countries, Guillain-Barre Syndrome (GBS) is the most common cause of acute neuromuscular paralysis, afflicting about 5,000 persons annually…
01 Jan 2013
PUFA Augmentation in Treatment of Major Depression
The purpose of this study is to determine if omega-3 fatty acid EPA will enhance and speed up response to…
01 Jan 2013
Long Term Post Operative Follow-Up of Cushing Syndrome
Although most patients with hypercortisolism can be diagnosed and treated the long-term effects of hypercortisolism and its treatment are unknown.
01 Jan 2013
Prevention of Alzheimer’s Disease by Vitamin E and Selenium (PREADVISE)
The Prevention of Alzheimer’s Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium…
01 Jan 2013
BEAM Trial
Purpose As many more premature infants survive, the numbers of these infants with health problems also has increased. The…
01 Jan 2013
TARGET
In the setting of percutaneous coronary revascularization, agents in the class known as platelet glycoprotein IIb/IIIa inhibitors have significantly reduced…
01 Jan 2013
TACTICS-TIMI 18
There is continued debate as to whether a routine, early invasive strategy is superior to a conservative strategy for the…
01 Jan 2013
EPIC
Platelets are believed to play a part in the ischemic complications of coronary angioplasty, such as abrupt closure of the…
01 Jan 2013
FIELD -Fenofibrate Intervention and Event Lowering in Diabetes
The FIELD trial “Fenofibrate Intervention and Event Lowering in Diabetes” aims to determine whether treatment with fenofibrate, a potent modifier…
01 Jan 2013
